These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35343940)

  • 1. Highlights in graft-vs-host disease from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Chen YB
    Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 3(1):17-23. PubMed ID: 35343940
    [No Abstract]   [Full Text] [Related]  

  • 2. Highlights in graft-vs-host disease from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 3(1):1-24. PubMed ID: 35343939
    [No Abstract]   [Full Text] [Related]  

  • 3. Highlights in Hodgkin lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Winter A
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 5(2):14-18. PubMed ID: 35343942
    [No Abstract]   [Full Text] [Related]  

  • 4. Highlights in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Mato A
    Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 2(1):17-19. PubMed ID: 35343936
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights in mantle cell lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Goy AH
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 6(2):18-23. PubMed ID: 35343947
    [No Abstract]   [Full Text] [Related]  

  • 6. Highlights in chronic graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    DiPersio JF
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):20-23. PubMed ID: 33843914
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary.
    Coombs CC
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 7(2):15-19. PubMed ID: 35343945
    [No Abstract]   [Full Text] [Related]  

  • 8. Highlights in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 2(1):1-20. PubMed ID: 35343935
    [No Abstract]   [Full Text] [Related]  

  • 9. Highlights in mantle cell lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 6(2):1-24. PubMed ID: 35343946
    [No Abstract]   [Full Text] [Related]  

  • 10. Highlights in graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):1-24. PubMed ID: 33843913
    [No Abstract]   [Full Text] [Related]  

  • 11. Highlights in leukemia and lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 7(2):1-20. PubMed ID: 35343944
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights in Hodgkin lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 5(2):1-20. PubMed ID: 35343941
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights in Graft-vs-Host Disease From the 60th American Society of Hematology Annual Meeting: Commentary.
    Jagasia M
    Clin Adv Hematol Oncol; 2019 Mar; 17 Suppl 6(3):16-18. PubMed ID: 31730585
    [No Abstract]   [Full Text] [Related]  

  • 14. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Evens AM
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):20-23. PubMed ID: 33843922
    [No Abstract]   [Full Text] [Related]  

  • 15. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Garcia-Manero G
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):20-23. PubMed ID: 33843866
    [No Abstract]   [Full Text] [Related]  

  • 16. Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Jacobson CA
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 10(3):19-23. PubMed ID: 33843918
    [No Abstract]   [Full Text] [Related]  

  • 17. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Barr PM
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):17-19. PubMed ID: 33843916
    [No Abstract]   [Full Text] [Related]  

  • 18. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition: commentary.
    Awan FT
    Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):14-17. PubMed ID: 33843856
    [No Abstract]   [Full Text] [Related]  

  • 19. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Salles G
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):13-16. PubMed ID: 33843858
    [No Abstract]   [Full Text] [Related]  

  • 20. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Davids MS
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):21-23. PubMed ID: 33843888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.